Biotech Values

[dav1234]

ABT-The FDA is expanding the approved use of Abbott's (ABT -1%) Humira to include treatment of moderate-to-severe ulcerative colitis in adults, when immunosuppressant medicines have not worked. The drug is currently approved for use in reducing the signs and symptoms of rheumatoid arthritis